These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28077060)

  • 1. Methods to characterize the structure of food powders - a review.
    Ho TM; Truong T; Bhandari BR
    Biosci Biotechnol Biochem; 2017 Apr; 81(4):651-671. PubMed ID: 28077060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of low amounts of amorphous content in hydrophobic active pharmaceutical ingredients with dynamic organic vapor sorption.
    Müller T; Schiewe J; Smal R; Weiler C; Wolkenhauer M; Steckel H
    Eur J Pharm Biopharm; 2015 May; 92():102-11. PubMed ID: 25779351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Powder diffraction crystallography of molecular solids.
    Harris KD
    Top Curr Chem; 2012; 315():133-77. PubMed ID: 21952843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of particle structure evolution during water sorption: skim and whole milk powders.
    Murrieta-Pazos I; Gaiani C; Galet L; Cuq B; Desobry S; Scher J
    Colloids Surf B Biointerfaces; 2011 Oct; 87(1):1-10. PubMed ID: 21612896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fat properties during homogenization, spray-drying, and storage affect the physical properties of dairy powders.
    Vignolles ML; Lopez C; Madec MN; Ehrhardt JJ; Méjean S; Schuck P; Jeantet R
    J Dairy Sci; 2009 Jan; 92(1):58-70. PubMed ID: 19109263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of small amorphous amounts in hydrophilic and hydrophobic APIs on storage stability of dry powder inhalation products.
    Müller T; Krehl R; Schiewe J; Weiler C; Steckel H
    Eur J Pharm Biopharm; 2015 May; 92():130-8. PubMed ID: 25769680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in processing food powders by using superfine grinding techniques: A review.
    Gao W; Chen F; Wang X; Meng Q
    Compr Rev Food Sci Food Saf; 2020 Jul; 19(4):2222-2255. PubMed ID: 33337081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse gas chromatography: considerations about appropriate use for amorphous and crystalline powders.
    Planinsek O; Buckton G
    J Pharm Sci; 2003 Jun; 92(6):1286-94. PubMed ID: 12761817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the Quality of Food Powder Products: The Challenges of Moisture-Mediated Phase Transformations.
    Mauer LJ; Forny L; Meunier VDM; Taylor LS
    Annu Rev Food Sci Technol; 2019 Mar; 10():457-478. PubMed ID: 30633567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of amorphous phases during the hydraulic conversion of α-TCP into calcium-deficient hydroxyapatite.
    Hurle K; Neubauer J; Bohner M; Doebelin N; Goetz-Neunhoeffer F
    Acta Biomater; 2014 Sep; 10(9):3931-41. PubMed ID: 24681375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of CO2 into amorphous alpha-cyclodextrin powder at different moisture contents - Part 2: Characterization of complexed powders and determination of crystalline structure.
    Ho TM; Howes T; Jack KS; Bhandari BR
    Food Chem; 2016 Sep; 206():92-101. PubMed ID: 27041303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of defects and amorphous structure produced in raffinose pentahydrate upon dehydration.
    Bates S; Kelly RC; Ivanisevic I; Schields P; Zografi G; Newman AW
    J Pharm Sci; 2007 May; 96(5):1418-33. PubMed ID: 17455351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of heat of adsorption to quantify amorphous content in milled pharmaceutical powders.
    Alam S; Omar M; Gaisford S
    Int J Pharm; 2014 Jan; 459(1-2):19-22. PubMed ID: 24315924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of IgG1 in spray-dried powders for inhalation.
    Schüle S; Schulz-Fademrecht T; Garidel P; Bechtold-Peters K; Frieb W
    Eur J Pharm Biopharm; 2008 Aug; 69(3):793-807. PubMed ID: 18477504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulation of CO2 into amorphous alpha-cyclodextrin powder at different moisture contents - Part 1: Encapsulation capacity and stability of inclusion complexes.
    Ho TM; Howes T; Bhandari BR
    Food Chem; 2016 Jul; 203():348-355. PubMed ID: 26948624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on flow characterization methods for cereal grain-based powders.
    Ambrose RP; Jan S; Siliveru K
    J Sci Food Agric; 2016 Jan; 96(2):359-64. PubMed ID: 26095631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of amorphous content by microcalorimetry.
    Kawakami K; Numa T; Ida Y
    J Pharm Sci; 2002 Feb; 91(2):417-23. PubMed ID: 11835201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
    Timmermann IL; Steckel H; Trunk M
    Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats.
    Carvalho SR; Watts AB; Peters JI; Liu S; Hengsawas S; Escotet-Espinoza MS; Williams RO
    Eur J Pharm Biopharm; 2014 Sep; 88(1):136-47. PubMed ID: 24859653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance.
    Van Eerdenbrugh B; Van Speybroeck M; Mols R; Houthoofd K; Martens JA; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G
    Eur J Pharm Sci; 2009 Oct; 38(3):270-8. PubMed ID: 19686846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.